💊 Nafithromycin: India’s First Indigenous Antibiotic 🇮🇳
A breakthrough in healthcare and a milestone in India’s journey toward self-reliance in medicine!

📌 Key Highlights:
- Unveiled by: Union Minister Dr. Jitendra Singh
- India’s first macrolide antibiotic, developed after 30 years of research.
- Uses:
- Designed to treat Community-Acquired Bacterial Pneumonia (CABP).
- 10x more effective than Azithromycin.
- Developed with: BIRAC collaboration and marketed as "Miknaf" by Wockhardt.

📍 Status:
- Phase 3 trials successfully completed.
- Awaiting final approval from Central Drugs Standard Control Organization (CDSCO).

✨ Significance:
A game-changer in combating antimicrobial resistance and addressing global health crises, strengthening India’s medical self-reliance.

#Nafithromycin #MadeInIndia #AntibioticInnovation #HealthcareRevolution #CDSCO #MedicalBreakthrough #SelfReliantIndia